Cost-effectiveness of introducing a domestic pneumococcal conjugate vaccine (PCV7-TT) into the Cuban national immunization programme

Autor: Anai García Fariñas, Nivaldo Linares-Pérez, Andrew Clark, María Eugenia Toledo-Romaní, Nathalie El Omeiri, Martha C. Marrero Araújo, Isabel Pilar Gonzálvez Luis, Gilda Toraño Peraza, Alicia Reyes Jiménez, Lena López Ambrón, Meiby C. Rodríguez, Beatriz Paredes, Mayelín Mirabal, Ivan Cuevas, Dagmar García-Rivera, Laura M. Rodríguez, Marisel Martínez, Yuri Valdés-Balbín, Susana Borroto Gutiérrez, Misladys Rodríguez Ortega, Ana María Gálvez, Maria F. Casanova, Dunia Chavez, Alaín Reyes, Yaima Figueredo Montes de Oca, Mercedes Fonseca, Martha Montes de Oca, Antonio Velázquez Águila, Iliana García Rodríguez, Cary Tere Llul Tombo, Juan C. Yanes Macías, Maria Elena Mesa, Yariser Ricardo, Niurka Molina Águila, Ernesto Legarreta Peňa, Dania Vega Mendoza, Gladys Abreu Gladys Fuentes, Miosotis Pérez Orta, Concepción Infante, María Cristina Reyes López, Lidia Teresita Ramos, Itciar Áreas, Adriana Rodríguez, Josefina Herrera López, Nordis Caridad Donatién Rojas, Lissett Batista Caluff, Nivia Cobas Limonta, null Moraima, Silvia Justiz Hernández, Malfran García, Luis Enrique Rondón Rondón, Bertha Isabel Rondón Peña, Magdevis Pajaro Medina, Daisy Díaz Teran, Mariela Cuza Ferrer, María Maren González, Samira Maceira Soto, José R. Guillén, Amanda Rodriguez Fonseca, Carlos Mederos Reyes, Alain Reyes Sebasco, Cara Janusz, Alina Pérez
Rok vydání: 2020
Předmět:
Zdroj: International Journal of Infectious Diseases, Vol 97, Iss, Pp 182-189 (2020)
ISSN: 1201-9712
Popis: Objectives: To evaluate the cost-effectiveness of introducing a domestic pneumococcal conjugate vaccine (PCV7-TT) into the Cuban National Immunization Program (NIP). Methods: We compared PCV7-TT given at two, four and six months of age to a scenario without PCV7-TT, over a ten-year period (2020–2029). We calculated the cost (Cuban pesos – CUP) per Disability Adjusted Life Year (DALY) averted from a Government perspective. We compared results from a static cohort model and a parsimonious prediction model informed by the serotype distribution among pneumococcal carriers and cases. We ran probabilistic and deterministic uncertainty analyses. Results: PCV7-TT could prevent 6897 (95% uncertainty interval, 4344–8750) hospitalizations and 189 (115–253) deaths in children
Databáze: OpenAIRE